Resonance Health : Appendix 3B Issue of Employee Shares

Name of entity

Resonance Health Ltd

ABN

96 006 762 492

1

+Class of +securities issued or to be issued

Fully paid ordinary shares (Shares)

2

Number of +securities issued or to be issued (if known) or

maximum number which may be issued

166,666 Shares

3

Principal terms of the

+securities (e.g. if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if

+convertible securities, the conversion price and dates for conversion)

Fully paid ordinary shares issued under the Resonance Health Limited Employee Share Plan - approved by members at the Annual General Meeting held 27 November 2014.

4

Do the +securities rank equally in all respects from the +issue date with an existing +class of quoted +securities?

If the additional +securities do not rank equally, please state:

• the date from which they do

• the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

• the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

Yes - Shares rank equally with Company's quoted shares.

5

Issue price or consideration

Shares are issued for nil consideration.

6

Purpose of the issue

(If issued as consideration for the acquisition of assets, clearly identify those assets)

Issue of 166,666 shares under the Resonance Health Limited - Employee Share Plan.

6a

Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A?

If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i

No

6b

The date the security holder resolution under rule 7.1A was passed

N/a

6c

Number of +securities issued without security holder approval under rule 7.1

N/a

6d

Number of +securities issued with security holder approval under rule 7.1A

N/a

6e

Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)

N/a

6f

Number of +securities issued under an exception in rule 7.2

N/a

6g

If +securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the

+issue date and both values. Include the source of the VWAP calculation.

N/a

6h

If +securities were issued under rule 7.1A for non-cash consideration, state date on

which valuation of consideration was released to ASX Market Announcements

N/a

6i

Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements

N/a

7

+Issue dates

Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A.

Cross reference: item 33 of Appendix 3B.

31 August 2016

Number

+Class

8

Number and +class of all

+securities quoted on ASX (including the +securities in section 2 if applicable)

166,666

+ 402,330,902402,497,568

Fully paid ordinary Shares